SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-186906
Filing Date
2020-07-02
Accepted
2020-07-02 16:39:20
Documents
17
Period of Report
2020-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d34680d8k.htm   iXBRL 8-K 44874
2 EX-10.1 d34680dex101.htm EX-10.1 68343
3 EX-10.2 d34680dex102.htm EX-10.2 9199
4 EX-10.3 d34680dex103.htm EX-10.3 6160
8 GRAPHIC g34680g10v39.jpg GRAPHIC 10742
9 GRAPHIC g34680g84b24.jpg GRAPHIC 5663
  Complete submission text file 0001193125-20-186906.txt   307921

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA adro-20200629.xsd EX-101.SCH 3081
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20200629_lab.xml EX-101.LAB 18122
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20200629_pre.xml EX-101.PRE 11412
10 EXTRACTED XBRL INSTANCE DOCUMENT d34680d8k_htm.xml XML 3343
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 201010057
SIC: 2834 Pharmaceutical Preparations